Conditions: Contraception
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 252
Healthy volunteers: yes

Brief summary:
This study will collect information on cycle control, acceptability and tolerability of the vaginal contraceptive ring (NuvaRing) as used in normal daily practice by Indian women.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: Ethinylestradiol + Etonogestrel Vaginal Ring (NuvaRing)
Intervention descriptions: intervention 1: Three cycles of NuvaRing use, each cycle consisting of etonogestrel 0.120 mg and ethinylestradiol 0.015 mg over a period of 21 days followed by 7 ring-free days.

Protocol document: